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Abstract
Objective: Geographic differences may provide insight into what factors influence the likelihood 
that a child is diagnosed with ASD in the US, yet there have been few nationally representative 
surveys that have explored this topic. The current study expands the limited literature by analyzing 
regional differences in ASD prevalence, service utilization, and the presence of unmet needs 
within a nationally representative sample of children.
Methods: Data were drawn from the 2014–2016 National Health Interview Survey (NHIS), a 
nationally representative household survey of the noninstitutionalized US population. Children 3–
17 were included in the analytic sample. Prevalence estimates accounted for the complex survey 
design of the NHIS, and differences between geographic regions were compared using logistic/
linear regressions with and without adjustment for child/family characteristics.
Results: The prevalence of ASD was highest in the Northeast (3.0%), followed by the Midwest 
(2.4%), South (2.4%), and West (2.3%). A significant difference was found between the Northeast 
and West (p<.05). However, after accounting for child and family characteristics, this difference 
was no longer significant. Children with ASD in the Northeast were the most likely to have seen a 
specialist in the past year. Approximately 1 in 8 children with ASD experienced at least one unmet 
need, but there were no differences found by geographic region.
Conclusions: Although differences in prevalence were not significant after adjustment, service 
utilization differences remained. It appears children with ASD in the Northeast utilize the greatest 
number of specialty services when compared to children with ASD from other parts of the country.
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Autism spectrum disorder (ASD) refers to a group of neurodevelopmental disorders 
characterized by impairments in social communication and the presence of repetitive 
behaviors or restricted interests.1 Over the past two decades, numerous studies have shown 
an overall trend of increasing ASD prevalence over time.2–5 Previous studies have also 
consistently shown large geographic variation in the prevalence of ASD in the United States 
at a single time point.2–3,6 Multiple factors are thought to contribute to regional variation in 
ASD prevalence, including sociodemographic characteristics and availability of autism-
related services.7–12
The most recent data from Centers for Disease Control and Prevention’s Autism and 
Developmental Disabilities Monitoring (ADDM) Network yielded an overall prevalence of 
1.7%, with surveillance sites in different states reporting ASD prevalence ranging from 1.3% 
to 2.9%.2 ASD prevalence estimates based on administrative sources have also shown 
variability by geography.13–14 These geographic differences in ASD prevalence are not fully 
understood, although the distribution of surveillance site estimates from ADDM may be the 
product of some sites relying on data from medical records alone, while others utilized both 
medical records as well as educational records. Nonetheless, studies based exclusively on a 
review of existing records are usually not well-suited to simultaneously explore the array of 
factors that might contribute to regional differences—especially for individual- or family-
level characteristics.
In the United States, sociodemographic characteristics have been observed to be associated 
with ASD prevalence. For instance, data from ADDM show that ASD prevalence is 
positively associated with increasing neighborhood-level socioeconomic status.15 One 
hypothesis for this association is that children of higher socio-economic status families are 
more likely to have access to services which may lead to ASD identification.16–17 It has also 
been posited that geographic differences in the availability of services might in themselves 
drive geographic differences in ASD prevalence,18 as previous research has suggested that a 
greater availability of autism services in urban areas might contribute to higher ASD 
prevalence in urban versus rural areas.19–20
An investigation of regional service utilization patterns among children with ASD may also 
provide insight in factors that may contribute to a higher ASD prevalence. In fact, two 
administrative studies of health service utilization (one utilizing data from the Healthcare 
Cost and Utilization Project (HCUP), the other from privately insured beneficiaries) have 
shown higher utilization of services in the Northeast than other regions of the country among 
children with ASD.21–22
As the observed prevalence of ASD continues to change over time, there is a need to 
investigate regional differences in ASD prevalence using recent and population-based 
information. Large national surveys such as the National Health Interview Survey (NHIS), 
from the National Center for Health Statistics (NCHS), are ideally suited for this type of 
investigation. The NHIS is designed to be nationally representative of the 
noninstitutionalized US population and collects timely, in-depth information on health 
conditions, health service utilization, and family sociodemographic characteristics. The 
primary goal of this study is to use recent NHIS data for children aged 3–17 years to 
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examine: 1) whether regional differences in ASD prevalence exist in the United States, and 
2) whether health service utilization and unmet needs differ among children with ASD living 
in different regions of the United States. Given notable health and service disparities seen 
between children living in rural and urban settings,23,24 a secondary analysis explores 
whether differential effects are seen by MSA status within different regions of the United 
States.
Methods
Data Source
The current study used data from the 2014–2016 NHIS. The NHIS is generally an in-person 
interview conducted in the respondent’s home, though some follow-up data collection may 
be conducted by telephone. The survey consists of three components, a family interview 
(collecting information about all members of the family), a sample adult interview 
(collecting detailed information about one randomly-selected adult per family), and a sample 
child interview (collecting detailed information about one randomly-selected child per 
family). The sample child interview is completed by a knowledgeable adult respondent, 
which is typically the child’s parent (approximately 91% of cases). Data for the current 
analysis utilized data from both the child and family interview. Response rates for the 2014–
2016 Sample Child component of the NHIS ranged from 61.9%−66.6%. For more 
information about NHIS, visit https://www.cdc.gov/nchs/nhis.htm.
Sample
A total of 30,530 children between the ages of 3 and 17 years were included in the analytic 
sample, of which 711 children were ever diagnosed as having autism spectrum disorder. 
Missing data on ASD occurred in approximately 0.9% of cases.
Measures
Autism spectrum disorder: An autism spectrum disorder case was defined based on an 
affirmative answer to the question “Has a doctor or other health professional ever told you 
that [child’s name] had autism, Asperger’s disorder, pervasive developmental disorder, or 
autism spectrum disorder?”
Geographic region: States were grouped into four regions used by the U.S. Census 
Bureau, including the Northeast (Maine, Vermont, New Hampshire, Rhode Island, New 
York, New Jersey, Pennsylvania, Massachusetts, Connecticut), Midwest (Ohio, Illinois, 
Indiana, Michigan, Wisconsin, Minnesota, Iowa, Missouri, North Dakota, South Dakota, 
Kansas, Nebraska), South (Delaware, Maryland, District of Columbia, West Virginia, 
Virginia, Kentucky, Tennessee, North Carolina, South Carolina, Georgia, Florida, Alabama, 
Mississippi, Louisiana, Oklahoma, Arkansas, Texas), and West (Washington, Oregon, 
California, Nevada, New Mexico, Arizona, Idaho, Utah, Colorado, Montana, Wyoming, 
Alaska, Hawaii).
Sociodemographic characteristics: Sociodemographic characteristics examined 
included the child’s sex, age (broken into age groups of 3–7, 8–12, 13–17 years of age), race 
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and ethnicity (non-Hispanic white, non-Hispanic black, non-Hispanic other, Hispanic), 
insurance status (any private, public only (includes Medicaid, Children’s Health Insurance 
Program (CHIP), and other state sponsored coverage), uninsured), family income recorded 
as a percentage of the federal poverty level (<100%, 100–199%, 200–399%, ≥400%), 
educational attainment of the highest educated family member (less than high school 
education, high school education or General Education Diploma (GED), greater than high 
school education), family structure (two parents, single parent, other), metropolitan 
statistical area (MSA) status (large (a county or group of counties that includes an urbanized 
area with a population of at least 50 thousand, and has a combined population total of 1 
million or more)), small (a county or group of counties that includes an urbanized area with 
a population of at least 50 thousand, but has a combined population total of less than 1 
million), not in a MSA), and survey year.
Service utilization characteristics: Respondents were asked a series of questions about 
the types of providers their child had seen in the past 12 months. The providers included a 
generalist (pediatrician, family medicine doctor, internal medicine doctor), a specialist, a 
mental health professional (psychiatrist, psychologist, psychiatric nurse, clinical social 
worker), or a therapist (physical therapist, speech therapist, respiratory therapist, audiologist, 
occupational therapist). A composite measure of specialty care was defined as children who 
had seen either a specialist, mental health professional, or therapist in the past 12 months. 
Respondents were also asked whether, and how many times, their child had received 
services at a series of locations, including a doctor’s office or clinic, an emergency 
department, or their own home. It was not possible to ascertain what specific services were 
received at each location.
Unmet needs: Respondents were asked whether their child needed a series of services but 
were unable to get them because it couldn’t be afforded, including: a) medical care, b) 
seeing a specialist, c) follow-up care, d) prescription medicines, and e) mental health care or 
counseling.
Statistical analysis
Demographic differences between regions among children with ASD were compared using 
Rao-Scott χ2 tests that accounted for the survey design (presented as F-values) --- 
significant overall F-tests were followed up with bivariate comparisons between regions and 
the demographic characteristic. Multivariate logistic regressions examined differences in 
ASD prevalence between geographic regions adjusted for child (age, sex, race and ethnicity, 
insurance status) and family (federal poverty level, family structure, highest adult education 
level, MSA status) characteristics and survey year. Additional multivariate logistic 
regressions examined service utilization differences and unmet needs among children with 
ASD by geographic regions both unadjusted and adjusted for child and family 
characteristics. As part of a secondary analysis, a series of interaction terms between region 
and MSA status were included in adjusted models to determine if geographic density had a 
differential effect in different parts of the country.
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All analyses were conducted using Stata 14.025 and made use of the survey sampling 
weights and the appropriate procedures to account for the complex survey design of the 
NHIS, as well as the imputed income data provided by NCHS. Weights accounted for 
nonresponse to the questionnaire and included a raking adjustment.
Results
Prevalence
Between 2014 to 2016, the prevalence of ASD among children 3 to 17 years of age in the 
United States was 2.5% (95% CI: 2.2–2.7). The prevalence of ASD was 3.0% (95% CI: 2.4–
3.8) in the Northeast, 2.4% (95% CI: 2.0–3.0) in the Midwest, 2.4% (95% CI: 1.9–2.9) in the 
South, and 2.3% (95% CI: 1.9–2.7) in the West. A significant difference was found between 
the Northeast and West (OR = 0.74, 95% CI: 0.55–0.99; p<0.05). However, after accounting 
for child and family characteristics, this difference was no longer significant (AOR = 0.88, 
95% CI: 0.64–1.20; p=0.42). A series of regression sensitivity analyses were used to 
examine the impact of each covariate in this adjusted model, revealing that the inclusion of 
children’s race and ethnicity (non-Hispanic white vs. all other races) had the greatest impact 
in shifting the association from significant to non-significant.
Demographics of Children with Autism Spectrum Disorder
Basic demographics by geographic region among children diagnosed with autism spectrum 
disorder appear in Table 1. Children with ASD in the Northeast and Midwest were more 
likely to be non-Hispanic white than children with ASD from other regions; children with 
ASD from the West were more likely to be Hispanic than children with ASD from other 
regions. Children with ASD in the Midwest were most likely to be living in a single parent 
household than children with ASD in other regions, but were less likely to be living in a 
household where the highest educated member had less than a high school education when 
compared to children with ASD from the South and West. Children with ASD were 
distributed similarly by MSA status across the four geographic regions, with approximately 
7 out of 8 children with ASD living in an MSA.
Service Utilization among Children with Autism Spectrum Disorder
More than 9 out of 10 children with ASD had received care at either a doctor’s office or 
clinic, emergency department, or their own home in the past 12 months, and approximately 4 
in 5 children with ASD had multiple visits at one of these locations (Table 2). Additionally, 
the vast majority of children with ASD had seen at least one of the four provider types 
within the past year (95.2%; SE: 1.2).
In unadjusted models, children with ASD in the South were least likely to have received care 
at home over the past year, while children with ASD in the Northeast were more likely to 
have seen a therapist compared to children with ASD in the South and West. These 
differences remained significant in adjusted models accounting for child and family 
characteristics. There were no differences across regions in the proportion of children with 
ASD who received care multiple times in a given location.
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Specialty Care
Approximately 4 in 5 children with ASD saw either a specialist, mental health professional, 
or therapist in the past 12 months (78.6%; SE: 2.0) (See Figure 1). In unadjusted models, 
children with ASD in the Northeast were the most likely to have seen at least one type of 
specialist. This difference remained significant after accounting for child and family 
characteristics. While about half of the children with ASD in the Northeast (54.5%; SE: 5.5) 
and Midwest (47.6%; SE: 5.5) had seen multiple types of specialists, only approximately 
one in three children with ASD from the South (36.2%; SE: 4.2) and West (34.6%; SE: 5.1) 
had seen multiple types of specialists.
Unmet needs
Overall, approximately 1 in 8 children with ASD (12.1%; SE: 2.0) experienced at least one 
unmet need in either medical care, seeing a specialist, follow-up care, prescription 
medication, or mental health care or counseling due to cost --- 9.3% (SE: 3.6) of children 
with ASD in the Northeast, 8.5% (SE: 2.7) of children with ASD in the Midwest, 15.2% 
(SE: 4.0) of children with ASD in the South, and 13.4% (SE: 4.0) of children with ASD in 
the West (see Table 3). Overall there was not a significant difference found by region either 
adjusted or unadjusted, although children in the South with ASD were significantly more 
likely to have an unmet medical care need than children with ASD in the West after 
adjustment for child and family characteristics.
Discussion
Prevalence
Based on data from the 2014–2016 NHIS, approximately 1 in 40 children aged 3–17 years 
(2.5%) had ever been diagnosed with ASD. Children in the Northeast had the highest 
prevalence compared to other geographic regions in the country. This is consistent with 
findings from the recent ADDM Network, where the New Jersey surveillance site reported 
the highest ASD prevalence2 and from the Nurses’ Health Study II, where children in the 
“New England” area were more likely to be diagnosed with ASD.18 Though the Nurses’ 
Health Study II found that race and ethnicity could not fully explain geographic differences, 
it is important to note that neither of these studies recruited a representative sample of 
children, particularly as it relates to race and ethnicity.
The present study, however, did find that regional differences could be explained by the 
inclusion of child and family characteristics. A sensitivity analysis revealed that the child’s 
race and ethnicity had the greatest impact in attenuating the magnitude of the association 
and also resulted in a shift from significant to non-significant. More specifically, since non-
Hispanic white children were more likely to be diagnosed with ASD and children in the 
Northeast were more likely to be non-Hispanic white relative to other regions,26 controlling 
for regional differences in the prevalence of non-Hispanic white children was sufficient to 
reduce the regional differences from statistically significant to non-significant.
It is also worth noting that MSA status was not significantly associated with prevalence, nor 
was there a significant difference found by MSA distribution across regions among children 
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with ASD, which are intriguing findings given previous research has found such a 
relationship.19–20 In addition, the secondary analysis, designed to explore whether 
geographic density may have a differential effect in four geographic regions, did not produce 
any significant interactions between MSA status and region, after adjustment for child and 
family characteristics. A previous US study reported that urban areas were more likely to be 
geographically closer to autism-related service providers and diagnosticians, and that 
geographic proximity to these providers was associated with an earlier age of ASD 
diagnosis.10 These studies differ from the present study in several important ways: they 
covered time periods at least 10 years older than NHIS data used in this study, used different 
measures of “urbanicity”, covered portions of a single US state or Denmark, and the data 
were obtained—at least in part—from existing registries or from health care providers.
Service Utilization and Specialty Care
The vast majority of children with ASD had seen a health care provider in the past year 
(95.2%), with approximately half of all children receiving care from a mental health 
professional (50.4%) or a therapist (50.4%). Yet, children with ASD in the Northeast were 
the most likely to have received any specialty care (specialist, mental health professional, or 
therapist) in the past year. In the South and West, approximately 1 in 4 children with ASD 
hadn’t received any specialty care, and less than half had seen multiple specialists, 
significantly lower proportions than children with ASD in the Northeast and Midwest. 
Children with ASD in the South and West were also less likely to have seen a therapist than 
children with ASD in the Northeast and Midwest.
Children with ASD in the South were the least likely to have received care at home 
compared to children with ASD throughout the country. Overall however, children with 
ASD were not more likely to have received care multiple times at any one location over the 
past 12 months, nor were any of the interaction terms significant as part of the secondary 
analysis. Previous research utilizing Medicaid claim data found that although the proportion 
of children with ASD receiving services in urban versus rural settings did not differ 
significantly, the number of services used were higher in urban areas.27
Service availability could affect the likelihood of a child receiving an ASD diagnosis. For 
example, Hoffman and colleagues18 found differing odds of ASD diagnosis depending on 
where the child was located, with children living in New England having the greatest odds of 
being diagnosed with ASD, while children living in central and southern US had lower odds 
of having received a diagnosis. The authors hypothesized that available diagnostic resources 
and services (such as those provided by the school under a child’s Individualized Education 
Program) may explain these differences, assuming increased use of specialists reflects 
higher availability of specialists. This hypothesis that service availability influences ASD 
diagnosis and ASD prevalence (see also Hill and colleagues28) is consistent with the present 
study’s unadjusted prevalence estimates and service utilization patterns. The exact 
mechanisms that may lead to these regional differences are not entirely clear. For example, 
Mazumdar and colleagues12 analyzed smaller “clusters” of ASD in California 
neighborhoods and concluded that neither “institutional diagnostic dynamics” nor families 
moving to areas with greater services explained differences seen in ASD prevalence.
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Unmet Needs
Although children with ASD in the Northeast showed the highest ASD prevalence, greatest 
service utilization, and most specialty care encounters, children with ASD were not less 
likely to have unmet needs regardless of geographic region for several measures. In contrast, 
a previous analysis of data on children with special health care needs (CSHCN) (defined 
broadly) from the 2009–2010 NS-CSHCN did identify regional differences in unmet need; 
in general it reported lower unmet need in the Northeast or Midwest, compared to the West 
and the South.29 Similarly, data from the 2005–2006 NS-CSHCN showed regional 
differences in unmet need for health services among children with ASD, with more unmet 
need in the West than the Northeast.8,30
It is unknown if differences between the current study and these previous findings are a 
reflection of changes in service availability for children with ASD over the past decade or 
perhaps differences between children with ASD with or without special health care needs. 
Given that children with ASD require additional services and experience greater levels of 
impairment than children with other special health care needs,31 findings for CSHCN may 
not be generalizable to children with ASD.
However, it is worth noting that the secondary analysis did not find differential effects of 
MSA status and region, nor MSA status alone, allowing for the possibility that some of the 
barriers previously identified to accessing care in rural settings for children with ASD32,33 
may have resolved. Additional research into the impact of efforts to train practitioners to 
work in rural environments, such as those recommended by the American Medical 
Association,34 may provide insight into changes seen.
Limitations
The NHIS has notable strengths in its large sample size and high response rate. However, 
caution regarding estimates is warranted because of several survey-related limitations. The 
reliance on parent reports could result in misreporting of child’s ASD diagnosis; such 
reports may also be subject to recall biases. Additionally, parents’ reports were not validated 
through clinical evaluation or educational records, and parents were only asked to reflect on 
lifetime diagnosis of ASD rather than current diagnoses; therefore children who have lost 
their original diagnosis would be included in the sample of children with ASD and the 
reported prevalence. Previous research has found that most ASD diagnoses persist, but there 
are reasons children who received a diagnosis in the past may no longer meet the criteria for 
a diagnosis, including, but not limited to, maturation, misdiagnosis, and effective treatment.
35
 Some children may also be less likely to meet diagnostic criteria for ASD after the 
introduction of revised diagnostic criteria with the DSM-5 in 2013.36 Additionally, although 
data was pooled over three years of NHIS interviews, there is still the potential for the small 
sample size of children with ASD to impact the interpretability of some findings. Namely, 
there may not be sufficient power to rule out a true difference between regions when the 
prevalence of an outcome for children with ASD was low. Finally, as the NHIS is a survey of 
the noninstitutionalized population, children living in places other than the household (e.g., 
long-term care facilities) are not included in the estimates.
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Conclusion
Although differences seen in the prevalence of ASD could be explained by child and family 
characteristics, such was not the case for differences seen in the receipt of specialized 
services by region. Additional research is warranted to further explore how child and family 
characteristics may lead to a disproportionate receipt of services or the ability to receive an 
ASD diagnosis.
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What’s New?
The current study expands the literature exploring geographic regions among children 
with ASD using a nationally representative sample. While children with ASD in the 
Northeast were found to have a greater utilization of specialized services, they were not 
less likely to have unmet needs when compared to children with ASD from other 
geographic regions.
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Figure 1. Number of type of specialists seen in the past year among children with autism 
spectrum disorder, by geographic region
a
 Significantly different from children in Northeast after adjustment for child and family 
characteristics (p<0.05)
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